REGN logo Regeneron Pharmaceuticals +
Regeneron Pharmaceuticals
+

Regeneron Pharmaceuticals's Revenue (2016 - 2025)

  • Regeneron Pharmaceuticals's annual revenue was $14.34 B in fiscal year 2025. The annual revenue increased $140.90 M from $14.20 B (in 2024) to $14.34 B (in 2025), representing a 0.99% year-over-year growth.

  • Regeneron Pharmaceuticals's quarterly revenue was $3.61 B in the quarter ending Mar 2026. The quarterly revenue increased $576.70 M from $3.03 B (in Q1: Dec 2025) to $3.61 B (in Q1: Dec 2026), representing a 19.04% year-over-year growth.

    • Over the past 10 years (2016 - 2025):
  • The highest annual revenue for Regeneron Pharmaceuticals was $16.07 B in fiscal year 2021.
  • The lowest annual revenue was $4.86 B in fiscal year 2016.
  • The average revenue was $10.24 B.

    • Learn more about Regeneron Pharmaceuticals's Revenue by Segment and Revenue by Region.

    Check out competitors to Regeneron Pharmaceuticals in a side-by-side comparison.

    Explore additional financial metrics for Regeneron Pharmaceuticals.


    Definition of Revenue :
  • Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Continue reading...

Regeneron Pharmaceuticals's Revenue Trend

2025

Regeneron Pharmaceuticals's annual revenue was $14.34 B in fiscal year 2025.

Regeneron Pharmaceuticals's quarterly revenue was $3.03 B(Q1: Mar 2025), $3.68 B(Q2: Jun 2025), $3.75 B(Q3: Sep 2025), $3.88 B(Q4: Dec 2025) in fiscal year 2025.

2024

Regeneron Pharmaceuticals's annual revenue was $14.20 B in fiscal year 2024.

Regeneron Pharmaceuticals's quarterly revenue was $3.15 B(Q1: Mar 2024), $3.55 B(Q2: Jun 2024), $3.72 B(Q3: Sep 2024), $3.79 B(Q4: Dec 2024) in fiscal year 2024.

2023

Regeneron Pharmaceuticals's annual revenue was $13.12 B in fiscal year 2023.

Regeneron Pharmaceuticals's quarterly revenue was $3.16 B(Q1: Mar 2023), $3.16 B(Q2: Jun 2023), $3.36 B(Q3: Sep 2023), $3.43 B(Q4: Dec 2023) in fiscal year 2023.

2022

Regeneron Pharmaceuticals's annual revenue was $12.17 B in fiscal year 2022.

Regeneron Pharmaceuticals's quarterly revenue was $2.97 B(Q1: Mar 2022), $2.86 B(Q2: Jun 2022), $2.94 B(Q3: Sep 2022), $3.41 B(Q4: Dec 2022) in fiscal year 2022.

2021

Regeneron Pharmaceuticals's annual revenue was $16.07 B in fiscal year 2021.

Regeneron Pharmaceuticals's quarterly revenue was $2.53 B(Q1: Mar 2021), $5.14 B(Q2: Jun 2021), $3.45 B(Q3: Sep 2021), $4.95 B(Q4: Dec 2021) in fiscal year 2021.

2020

Regeneron Pharmaceuticals's annual revenue was $8.50 B in fiscal year 2020.

Regeneron Pharmaceuticals's quarterly revenue was $1.83 B(Q1: Mar 2020), $1.95 B(Q2: Jun 2020), $2.29 B(Q3: Sep 2020), $2.42 B(Q4: Dec 2020) in fiscal year 2020.

2019

Regeneron Pharmaceuticals's annual revenue was $6.56 B in fiscal year 2019.

Regeneron Pharmaceuticals's quarterly revenue was $1.37 B(Q1: Mar 2019), $1.58 B(Q2: Jun 2019), $1.74 B(Q3: Sep 2019), $1.86 B(Q4: Dec 2019) in fiscal year 2019.

2018

Regeneron Pharmaceuticals's annual revenue was $6.71 B in fiscal year 2018.

Regeneron Pharmaceuticals's quarterly revenue was $1.51 B(Q1: Mar 2018), $1.61 B(Q2: Jun 2018), $1.66 B(Q3: Sep 2018), $1.93 B(Q4: Dec 2018) in fiscal year 2018.

2017

Regeneron Pharmaceuticals's annual revenue was $5.87 B in fiscal year 2017.

Regeneron Pharmaceuticals's quarterly revenue was $1.32 B(Q1: Mar 2017), $1.47 B(Q2: Jun 2017), $1.50 B(Q3: Sep 2017), $1.58 B(Q4: Dec 2017) in fiscal year 2017.

2016

Regeneron Pharmaceuticals's annual revenue was $4.86 B in fiscal year 2016.

Regeneron Pharmaceuticals's quarterly revenue was $1.20 B(Q1: Mar 2016), $1.21 B(Q2: Jun 2016), $1.22 B(Q3: Sep 2016), $1.23 B(Q4: Dec 2016) in fiscal year 2016.

Continue reading...

Regeneron Pharmaceuticals's Revenue (Year-over-Year Change)

2015 0
2016 +18.44
2017 +20.82
2018 +14.28
2019 -2.28
2020 +29.58
2021 +89.14
2022 -24.26
2023 +7.76
2024 +8.27
2025 +0.99

2025

Regeneron Pharmaceuticals’s annual revenue increased +0.99% during fiscal year 2025 compared to 2024. It represents a growth of $140.90 M from $14.20 B (in 2024) to $14.34 B (in 2025).

2024

Regeneron Pharmaceuticals’s annual revenue increased +8.27% during fiscal year 2024 compared to 2023. It represents a growth of $1.08 B from $13.12 B (in 2023) to $14.20 B (in 2024).

2023

Regeneron Pharmaceuticals’s annual revenue increased +7.76% during fiscal year 2023 compared to 2022. It represents a growth of $944.30 M from $12.17 B (in 2022) to $13.12 B (in 2023).

2022

Regeneron Pharmaceuticals’s annual revenue decreased -24.26% during fiscal year 2022 compared to 2021. It represents a decline of $3.90 B from $16.07 B (in 2021) to $12.17 B (in 2022).

2021

Regeneron Pharmaceuticals’s annual revenue increased +89.14% during fiscal year 2021 compared to 2020. It represents a growth of $7.57 B from $8.50 B (in 2020) to $16.07 B (in 2021).

2020

Regeneron Pharmaceuticals’s annual revenue increased +29.58% during fiscal year 2020 compared to 2019. It represents a growth of $1.94 B from $6.56 B (in 2019) to $8.50 B (in 2020).

2019

Regeneron Pharmaceuticals’s annual revenue decreased -2.28% during fiscal year 2019 compared to 2018. It represents a decline of $153.20 M from $6.71 B (in 2018) to $6.56 B (in 2019).

2018

Regeneron Pharmaceuticals’s annual revenue increased +14.28% during fiscal year 2018 compared to 2017. It represents a growth of $838.57 M from $5.87 B (in 2017) to $6.71 B (in 2018).

2017

Regeneron Pharmaceuticals’s annual revenue increased +20.82% during fiscal year 2017 compared to 2016. It represents a growth of $1.01 B from $4.86 B (in 2016) to $5.87 B (in 2017).

2016

Regeneron Pharmaceuticals’s annual revenue increased +18.44% during fiscal year 2016 compared to 2015. It represents a growth of $756.70 M from $4.10 B (in 2015) to $4.86 B (in 2016).

Continue reading...

Regeneron Pharmaceuticals Revenue History

Sign in to download table

Period Revenue Year-over-Year Change
FY 2025
$14.34 B $140.90 M 0.99%
Q4: Dec 25 $3.88 B $95.10 M 2.51%
Q3: Sep 25 $3.75 B $33.60 M 0.9%
Q2: Jun 25 $3.68 B $128.50 M 3.62%
Q1: Mar 25 $3.03 B -$116.30 M 3.7%
FY 2024
$14.20 B $1.08 B 8.27%
Q4: Dec 24 $3.79 B $354.90 M 10.33%
Q3: Sep 24 $3.72 B $358.00 M 10.65%
Q2: Jun 24 $3.55 B $389.00 M 12.32%
Q1: Mar 24 $3.15 B -$17.10 M 0.54%
FY 2023
$13.12 B $944.30 M 7.76%
Q4: Dec 23 $3.43 B $19.90 M 0.58%
Q3: Sep 23 $3.36 B $426.50 M 14.53%
Q2: Jun 23 $3.16 B $300.90 M 10.53%
Q1: Mar 23 $3.16 B $197.00 M 6.64%
FY 2022
$12.17 B -$3.90 B 24.26%
Q4: Dec 22 $3.41 B -$1.54 B 31.05%
Q3: Sep 22 $2.94 B -$516.60 M 14.96%
Q2: Jun 22 $2.86 B -$2.28 B 44.4%
Q1: Mar 22 $2.97 B $436.40 M 17.26%
FY 2021
$16.07 B $7.57 B 89.14%
Q4: Dec 21 $4.95 B $2.53 B 104.37%
Q3: Sep 21 $3.45 B $1.16 B 50.51%
Q2: Jun 21 $5.14 B $3.19 B 163.24%
Q1: Mar 21 $2.53 B $700.50 M 38.32%
FY 2020
$8.50 B $1.94 B 29.58%
Q4: Dec 20 $2.42 B $559.40 M 30.02%
Q3: Sep 20 $2.29 B $550.30 M 31.56%
Q2: Jun 20 $1.95 B $374.20 M 23.72%
Q1: Mar 20 $1.83 B $455.60 M 33.19%
FY 2019
$6.56 B -$153.20 M 2.28%
Q4: Dec 19 $1.86 B -$64.30 M 3.34%
Q3: Sep 19 $1.74 B $80.20 M 4.82%
Q2: Jun 19 $1.58 B -$30.22 M 1.88%
Q1: Mar 19 $1.37 B -$138.89 M 9.19%
FY 2018
$6.71 B $838.57 M 14.28%
Q4: Dec 18 $1.93 B $345.35 M 21.82%
Q3: Sep 18 $1.66 B $162.82 M 10.85%
Q2: Jun 18 $1.61 B $137.91 M 9.38%
Q1: Mar 18 $1.51 B $192.49 M 14.59%
FY 2017
$5.87 B $1.01 B 20.82%
Q4: Dec 17 $1.58 B $355.62 M 28.99%
Q3: Sep 17 $1.50 B $280.55 M 22.99%
Q2: Jun 17 $1.47 B $257.49 M 21.23%
Q1: Mar 17 $1.32 B $118.14 M 9.84%
FY 2016
$4.86 B $756.70 M 18.44%
Q4: Dec 16 $1.23 B $128.75 M 11.73%
Q3: Sep 16 $1.22 B $82.70 M 7.27%
Q2: Jun 16 $1.21 B $214.01 M 21.43%
Q1: Mar 16 $1.20 B $331.24 M 38.09%

Frequently Asked Questions

What is the annual revenue of Regeneron Pharmaceuticals?

In fiscal year 2025, Regeneron Pharmaceuticals's revenue was $14.34 Billion.

How much did Regeneron Pharmaceuticals's revenue change in the last year?

Regeneron Pharmaceuticals's revenue increased by +0.99% (+$140.90 Million) in 2025 compared to 2024.

What is Regeneron Pharmaceuticals's most recent quarterly revenue?

In the first quarter (Q1) of 2026, Regeneron Pharmaceuticals reported a revenue of $3.61 Billion.

What is Regeneron Pharmaceuticals's revenue per share (TTM)?

Regeneron Pharmaceuticals's revenue per share over the trailing twelve months is $143.46.

What is Regeneron Pharmaceuticals's revenue per employee?

In the fiscal year 2025, Regeneron Pharmaceuticals's revenue per employee was $930.75 K.

What is the annual net income of Regeneron Pharmaceuticals?

In fiscal year 2025, Regeneron Pharmaceuticals's net income was $4.50 Billion.

What is Regeneron Pharmaceuticals's biggest product segment, and what is its revenue?

Collaboration Revenue is Regeneron Pharmaceuticals's biggest product segment, generating $7.33 Billion in revenue for fiscal year 2025.

What is Regeneron Pharmaceuticals's net income per employee?

In the fiscal year 2025, Regeneron Pharmaceuticals's net income per employee was $292.34 K.

Related

People Also Search For

Submit feedback to Bullfincher